文献速递关节外科创伤骨科

抗生素骨水泥间隔物关节液α防御素检测的临床价值

What is the Clinical Utility of Synovial Alpha Defensin Testing of Antibiotic Spacers Before Reimplantation?
PubMed 文献 · J Arthroplasty · 2021-02-05

结果显示单独AD检测敏感性0%、特异性96%,且加入其他常用实验室检测未提高诊断性能。

要点

  • 单独AD检测敏感性0%,特异性96%,预测重复感染价值低。
  • AD检测阳性3个间隔物(6%),其中2个再植入后1年未失败。
  • 加入AD检测未提高常用关节液和血清标志物的诊断性能。

核心结论

  • 单独关节液AD检测预测二期翻修后重复感染的敏感性为0%,预测价值低。
  • 将AD检测加入常用关节液和血清感染标志物未提高诊断性能。

研究设计与样本

  • 单中心回顾性队列研究,纳入2016至2019年因假体周围感染行二期翻修病例。

主要发现

  • 5个间隔物基于MSIS标准判定为持续感染,其中1个再切除、4个再植入后无感染并发症。
  • 48例判定未感染患者均再植入,术后1年7例(13%)因感染失败。
  • 3个间隔物(6%)AD检测阳性,其中2个再植入后1年未失败。
  • 单独AD检测敏感性0%,特异性96%。

关键数值与推荐

  • 单独AD检测敏感性0%,特异性96%。
  • 未感染组再植入后1年感染失败率13%(7/48例)。

临床怎么用

  • 基于现有证据,不推荐单独使用关节液AD检测预测抗生素间隔物持续感染。
  • AD检测加入常用血清和关节液标志物未显示额外诊断价值。

局限性

  • 回顾性单中心设计,证据等级为IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to evaluate the diagnostic performance of standalone alpha defensin (AD) testing of antibiotic spacers during two stage exchange and to determine if the addition of AD testing to other commonly used laboratory tests improves the ability to detect persistent infection in an antibiotic spacer. METHODS: Cases of two-stage exchange for periprosthetic joint infection from 2016 to 2019 at a single institution were retrospectively reviewed. Cases were classified as persistently infected or not infected in accordance with 2014 and 2018 Musculoskeletal Infection Society criteria to determine if AD provided any clinical utility beyond the other commonly used tests that make up both criteria. Delphi Consensus criteria at 1 year were used as the gold standard for determining recurrent periprosthetic joint infection. RESULTS: Fifty-two spacers (25 hips and 27 knees) in 51 patients were included for analysis. Five spacers were persistently infected based on Musculoskeletal Infection Society criteria. One spacer underwent reresection and the remaining 4 underwent reimplantation with no subsequent infectious complications. All 48 patients who were categorized as not infected underwent reimplantation; at 1 year postoperatively, 7 (13%) had failed due to infection. Three spacers (6%) had a positive AD test. Two spacers with positive AD tests underwent reimplantation, neither had failed at 1 year postoperatively. Sensitivity of standalone AD testing was 0%, and specificity was 96%. CONCLUSION: Standalone AD testing for the purpose of predicting repeat infection after two-stage exchange arthroplasty exhibits sensitivity of 0% and low predictive value. Addition of synovial AD testing did not increase the diagnostic performance of commonly used synovial and serologic markers of infection. LEVEL OF EVIDENCE: IV-retrospective cohort study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Carender CN, DeMik DE, Otero JE, et al. What is the Clinical Utility of Synovial Alpha Defensin Testing of Antibiotic Spacers Before Reimplantation? J Arthroplasty. 2021. PMID: 33648841. doi:10.1016/j.arth.2021.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。